| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |